DaShenLin Pharmaceutical Group Co (SHSE:603233) Short Interest


SHSE:603233 DaShenLin Pharmaceutical Group Co Ltd SHSE:603233
95 GF Score
Price ¥14.86
GF Value ¥18.69
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is DaShenLin Pharmaceutical Group Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


DaShenLin Pharmaceutical Group Co Short Interest Competitor Comparison

For the Pharmaceutical Retailers subindustry, DaShenLin Pharmaceutical Group Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaShenLin Pharmaceutical Group Co Short Interest vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaShenLin Pharmaceutical Group Co's Short Interest distribution charts can be found below:

* The bar in red indicates where DaShenLin Pharmaceutical Group Co's Short Interest falls into.


SHSE:603233
95GF Score
DaShenLin Pharmaceutical Group Co Ltd SHSE:603233
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is DaShenLin Pharmaceutical Group Co (SHSE:603233) Overvalued in 2026?

Based on GuruFocus' analysis, DaShenLin Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥14.86 is trading 20.5% below its estimated GF Value™ of ¥18.69. GuruFocus considers DaShenLin Pharmaceutical Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:603233:

  • Short Interest:
  • GF Value™: ¥18.69 vs. price of ¥14.86 (20.5% below fair value)
  • GF Score™: 95/100 with 4 warning signs

No single metric tells the full story. See the SHSE:603233 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DaShenLin Pharmaceutical Group Co Business Description

Address No. 410-1, Longxi Avenue, Liwan District, Guangdong Province, Guangzhou, CHN, 510000
DaShenLin Pharmaceutical Group Co Ltd is engaged in the pharmaceutical manufacturing, retail, and wholesale business. The company is based on the development of the pharmacy chain. It primarily offers Chinese herbal medicine such as antibiotics and biochemical drugs. The business activities are geographically carried out through China.
95GF Score

Get the complete analysis for SHSE:603233

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥14.86
Price
¥18.69
GF Value